文献速递主动脉疾病

感染性主动脉瘤的管理:短期与中期结局

Management of Infectious Aortic Aneurysms: Short- and Mid-TermOutcomes.
PubMed 文献 · Ann Vasc Surg · 2025-03-05

本研究回顾性纳入2009年9月至2023年10月47例确诊感染性主动脉瘤患者,评估不同治疗方式的死亡率。根治性开放手术组30天、1年、3年生存率分别为84%、75.6%、60.6%,血管内治疗组分别为91.7%、41.7%、20.8%,单纯药物治疗组仅37.5%和0%。作者结论认为药物联合根治性开放手术有效,血管内治疗结果可接受,单纯药物治疗仅适用于无法手术者。

要点

  • 47例感染性主动脉瘤患者中,根治性手术27例(57.4%),血管内治疗12例(25.5%),单纯药物8例(17%)。
  • 根治性手术组3年生存率60.6%,血管内治疗组20.8%,单纯药物组0%。
  • 围手术期感染复发仅1例,抗生素平均术前用8天、术后用3个月。

核心结论

  • 药物治疗联合根治性开放手术是治疗感染性主动脉瘤的有效方式。
  • 血管内治疗的结果可接受。
  • 单纯药物治疗应仅保留给因短期死亡率极高而无法手术的患者。

研究设计与样本

  • 回顾性预后注册登记研究(Retrospective and Prognostic Registry of Aortic Infections),纳入2009年9月至2023年10月确诊的47例感染性主动脉瘤患者,平均年龄67±10.8岁,评估30天、1年和3年结局。

主要发现

  • 动脉瘤位置:弓部4%、降胸主动脉21%、胸腹主动脉30%、近肾动脉4%、肾下腹主动脉41%。
  • 病原体:甲氧西林敏感金黄色葡萄球菌43%、沙门菌13%、大肠埃希菌9%、其他菌种35%。
  • 根治性手术27例(57.4%),其中牛心包管状异种移植物22例、冷冻保存同种移植物3例;血管内治疗12例(25.5%);单纯药物治疗8例(17%)。
  • 总体30天、1年、3年生存率分别为78.7%、52.4%、44.4%;根治性手术组分别为84%、75.6%、60.6%,血管内治疗组分别为91.7%、41.7%、20.8%。
  • 单纯药物治疗持续感染组生存率为37.5%和0%;围手术期感染复发1例;抗生素平均术前使用8天、术后使用3个月。

临床怎么用

  • 标准治疗包括术前和术后抗生素以及使用生物材料重建的开放根治性手术。
  • 对于有开放手术禁忌的患者使用血管内治疗。
  • 在紧急情况下可提出替代性「桥接」技术,即放置覆膜支架后行二期开放手术重建。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infectious aortic aneurysms are a rare but life-threatening condition due to their rapid development. Their management is multidisciplinary. The main purpose of this study was to evaluate the mortality of patients treated for infectious aortic aneurysm (IAA) by different types of treatments. Secondary objectives were to evaluate infectious recurrences and the factors influencing mortality with this management. METHODS: Between September 2009 and October 2023, all the patients with an IAA confirmed by the clinical, biological, microbiological, radiological, and nuclear medicine data were included. Standard treatment included preoperative and postoperative antibiotics and open radical surgery with reconstruction using biological material. Endovascular treatment was used in patients with contraindication to open surgery. An alternative "bridge" technique was proposed in emergencies and consisted of the placement of a covered stent graft followed by secondary open surgical reconstruction. The clinical, biological, bacteriological, and imaging data were collected in the Retrospective and Prognostic Registry of Aortic Infections registry, with a 30-day, 1-year, and 3-year evaluation. Infectious recurrences were studied. RESULTS: The IAA diagnosis was confirmed in 47 patients with a mean age of 67 ± 10.8 years. Aneurysms were located in the arch (4%), the descending thoracic aorta (21%), the thoracoabdominal aorta (30%), the juxta-renal (4%), and the infrarenal abdominal (41%) aorta. The involved microorganisms were methicillin-sensitive S. aureus (43%), Salmonella (13%), E. coli (9%), and other species (35%). Radical surgery was performed in 27 patients (57.4%): bovine pericardial tubular xenografts and cryopreserved allografts were used in 22 and 3 cases, respectively. Endovascular treatment was performed in 12 patients (25.5%) Medical treatment only was used in 8 cases (17%). The overall 30-day, 1-year, and 3-years survival rates were 78.7%, 52.4%, and 44.4%, respectively. In the radical surgery group, survival rates were 84%, 75.6%, and 60.6%, respectively, vs. 91.7%, 41.7%, and 20.8% in the endovascular group. In the medical group with persistent infection, survival rates were 37.5% and 0%. The average length of antibiotic treatment was 8 days preoperatively and 3 months postoperatively. Periaortic infectious recurrence was observed in 1 patient. CONCLUSION: The combination of medical treatment and radical open surgery is effective in the treatment of IAA. Endovascular treatment yields acceptable results. Medical treatment alone should only be reserved for patients who are inoperable due to a very high short-term mortality.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Frisch S, Settembre N, Belkorissat RA, et al. Management of Infectious Aortic Aneurysms: Short- and Mid-TermOutcomes. Ann Vasc Surg. 2025. PMID: 40054606. doi:10.1016/j.avsg.2025.01.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。